Nathalie Johnson

Dr. Nathalie Johnson is an associate professor in the departments of Medicine and Oncology and Director of the division of Hematology at McGill University. She holds the Louis Lowenstein Chair in Hematology & Oncology at McGill University. She is a hematologist at the Jewish General Hospital in Montreal who performs translational and clinical research since 2010. Her research focuses on studying mechanisms of therapeutic resistance to conventional and novel therapies and identifying early relapsed lymphoma using plasma circulating tumor DNA. She is the primary investigator of several clinical trials that test novel treatments for patients with newly diagnosed or relapsed lymphoma. She is also the program director for Clinical Investigator Program at McGill University and past President of the Canadian Society for Clinical Investigation (CSCI).